Top insider buys: Jan 22 – Jan 28, 2024

The largest open-market purchases company insiders reported on SEC Form 4 between Jan 22 – Jan 28, 2024.

Week 4, 2024

#	Company	Who bought	Shares	Value	Source
1	ACET Adicet Bio, Inc.	2 officers/directors Cluster buy ORBIMED ADVISORS LLC, Carl L. Gordon	6,250,000	$15.0M	SEC filings
2	EWTX Edgewise Therapeutics, Inc.	2 officers/directors Cluster buy Peter A. Thompson, ORBIMED ADVISORS LLC	909,090	$10.0M	SEC filings
3	TCBI TEXAS CAPITAL BANCSHARES INC/TX	2 officers/directors Cluster buy Robert W. Stallings, Laura L. Whitley	23,000	$524K	SEC filings
4	LSXMK Liberty Media Corp	10% Owner BERKSHIRE HATHAWAY INC	1,441,686	$44.7M	SEC filings
5	BMEZ BlackRock Health Sciences Term Trust	10% Owner Saba Capital Management, L.P.	884,535	$13.4M	SEC filings
6	BIGZ BlackRock Innovation & Growth Term Trust	10% Owner Saba Capital Management, L.P.	1,755,378	$13.1M	SEC filings
7	ECAT BlackRock ESG Capital Allocation Term Trust	10% Owner Saba Capital Management, L.P.	663,178	$11.0M	SEC filings
8	VRDN Viridian Therapeutics, Inc.\DE	Director Fairmount Funds Management LLC	476,190	$10.0M	SEC filings
9	BCAT BlackRock Capital Allocation Term Trust	10% Owner Saba Capital Management, L.P.	507,451	$7.7M	SEC filings
10	CALC CalciMedica, Inc.	2 separate filers Fred A. Middleton, Sanderling Venture Partners VI LP	1,358,768	$5.0M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.